⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

ERAS

Erasca, Inc.

Healthcare · Biotechnology

16.82USD

+1.1200 (+7.13%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Fetching financial statements from SEC filings…

In $M except per-shareQ2 FY26Q1 FY26Q4 FY25*Q3 FY25Q2 FY25Q1 FY25Q4 FY24*Q3 FY24
Revenue————————
Cost of Revenue————————
Gross Profit————————
Operating Income-48-188-33-35-38-36-36-37
Net Income-44-183-29-31-34-31-32-31
EPS (Diluted)$-0.14$-0.60$-0.10$-0.11$-0.12$-0.11$-0.09$-0.11

* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)